Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Daunorubicin MeSH Descriptor Data 2025


MeSH Heading
Daunorubicin
Tree Number(s)
D02.455.426.559.847.562.050.200
D04.615.562.050.200
D09.408.051.059.200
Unique ID
D003630
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D003630
Scope Note
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.
Entry Term(s)
Cerubidine
Dauno-Rubidomycine
Daunoblastin
Daunoblastine
Daunomycin
Daunorubicin Hydrochloride
NSC-82151
Rubidomycin
Rubomycin
Pharm Action
Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Numbers
ZS7284E0ZP
0
UD984I04LZ
Related Numbers
20830-81-3
23541-50-6
UD984I04LZ
CAS Type 1 Name
5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
Public MeSH Note
80; was DAUNOMYCIN 1966-79
Online Note
use DAUNORUBICIN to search DAUNOMYCIN 1966-79
History Note
80; was DAUNOMYCIN 1964-79 (Prov 1964-65)
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2013/07/08
Daunorubicin Preferred
Cerubidine Narrower
NSC-82151 Narrower
Daunorubicin Hydrochloride Narrower
Daunoblastin Narrower
page delivered in 0.134s